Potent anti‐myeloma activity of the TOPK inhibitor OTS514 in pre‐clinical models
Andrew Stefka(University of Chicago), Andrzej Jakubowiak(University of Chicago Medical Center)
Cited by 19
Related Papers
Commensal bacteria protect against food allergen sensitization
|Proceedings of the National Academy of Sciences|2014|790
Review article: fungal microbiota and digestive diseases
|Alimentary Pharmacology & Therapeutics|2014|132
Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011).
|Journal of Clinical Oncology|2020|122
Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study
|British Journal of Haematology|2012|62